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Characteristics of Catch-Up 
Growth in Very Low Birth Weight 
Infants (<1500 g)




Features of catch-up growth are not well established in very low birth weight 
infants (VLBW). The aim of this study is to analyze the catch-up growth in height 
and some factors associated in a cohort of VLBW (<1500 g) from birth to age 
14 years. Retrospective registration of weight and height at birth and ages 0.5, 
1, 2, 3, 4, 6, 8, 10, 12 and 14 years in a cohort of 170 VLBW have been recorded 
Anthropometric variables were compared with those from a control group. Sixty-
nine (40.6%) were small for gestational age (SGA subgroup) and 101 (59.4%) 
were appropriate for gestational age (AGA subgroup). Thirty-seven (21.8%) were 
extremely low birth weight (ELBW), and 32 (18.8%) extremely preterm (EPT). 
At age 2, 4 and 10 years, 49.4%, 78.9% and 87.1% VLBW, respectively, did reach 
normal height. Between 4 and 10 years of age, only 8.2% of VLBW reached nor-
mal height. At 10 years of age, 7% of VLBW (1000–1500 g) and 35% of ELBW 
(<1500 g) showed short stature (p = 0.001). Almost the entire sample of VLBW 
with normal height at age 2, 4 and 10 have reached an adequate catch-up growth in 
weight in the previous evaluations. ELBW, SGA and EPT were found to be inde-
pendent predictors for inadequate catch-up growth in height at 2, 4, and 10 years 
of age. The growth pattern of children born preterm has particular features: they 
have a lower rate and/or slowness in the catch-up growth in height with respect to 
that described in full-term small-for-gestational-age infants. Catch-up in weight 
appears to be a decisive factor for catch-up in height, and, on this basis, we recom-
mend a rigorous nutritional follow-up in these individuals. If these measures do not 
help improve catch-up in height, they may be eligible for the establishment of rhGH 
therapy.
Keywords: Catch-up growth, Extremely low birth weight, Growth pattern, 
Intrauterine growth retardation, Preterm infant, Very low birth weight infant
1. Introduction
Full-term infants who present with intrauterine growth restriction constitute a 
varied group with multifactorial conditions. These infants, along with high rates 
of perinatal morbidity and mortality, undergo an increased risk of cardiovascular 
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and/or metabolic disease in adult life [1]. They subsequently experience an accel-
erated compensating growth, known as catch-up growth, which usually ceases at 
age 2 [2–4]. As a matter of fact, those children whose catch-up is inadequate have 
low chance to reach a normal size in adult life; that is one of the approved indica-
tions for the treatment with recombinant growth hormone [5–8].
Nevertheless, the features of catch-up growth are not well characterized in 
very preterm infants (<32 weeks of gestation) or very low birth weight infants 
(<1.500 g). In accordance with current knowledge, there is evidence that supports 
the need to experience adequate extrauterine growth in order to acquire optimal 
development of all their organic capacities. The increased survival rate of very 
low birth weight infants (<1500 g) at present time, as a consequence of the recent 
advances in obstetric and perinatal care, entails a higher risk of sensorineural 
morbidity and/or disability [5, 9, 10]. In any case, the follow-up of these patients, 
even though there is no actual consensus, suggests that this catch-up could extend 
to a later stage, and so condition the prognosis of adult size [11–18].
Catch-up is defined as a fast paced growth after a period of growth failure 
whose aim is to approach to the measurements of normal term-born infants [2–4]. 
When this event fails to develop during the initial stages of life, neurological 
deficits like behavioral difficulties and neurocognitive deficits in very preterm 
infants are likely to be found [19–21]. In addition, correlations between rapid and 
early growth (especially of weight) in preterm-born infants and the progression to 
metabolic syndrome in adulthood have been reported [19, 22, 23]. There is still poor 
understanding on the factors that determine when catch-up growth occurs in very 
preterm infants or very low birth weight infants, but it is well-known that low birth 
weight, early gestational age and medical complications have a particularly negative 
effect on postnatal growth [16]. In addition, the catch-up growth in weight in these 
children, which presents simultaneously to catch-up growth in length, has been less 
frequently studied, even though it has been proved that caloric intake has a positive 
impact on postnatal growth in preterm infants [24–27].
The main aim of the work is to perform a longitudinal descriptive study of 
anthropometric measurements in a group of very low birth weight (VLBW) infants, 
aged from birth to 14 years of age, and to analyze the features of catch-up growth in 
height and some of the factors associated in these children.
2. Methods
There is a specific program in our region (Comunidad Foral de Navarra), 
fostered by the Regional Health Service, that intends to promote healthy lifestyle 
and monitors child growth and development. By means of periodic consultation 
(usually at birth and during the first year, and ages 0.5, 1, 2, 3, 4, 6, 8, 10, 12 and 
14 years), the program accomplish the registration of anthropometric measure-
ments (weight and height) and saves different data in the clinical records.
These children, who represent a cohort of VLBW infants (<1500 g), have 
been evaluated by a pediatrician and/or pediatric nurse by the use of the different 
facilities available (our public Health Service guarantees universal accessibility in 
distance and personal assistance). The different consultations were programmed 
at birth and ages 0.5, 1, 2, 3, 4, 6, 8, 10, 12 and 14 years. A brief medical history, 
basic physical exam and the anthropometric measurements (weight and height) 
were recorded. The only requirements to be included were a Caucasian origin from 
Spanish parents, and the birth place (the Neonatal Unit of the Navarra Hospital 
Complex in Pamplona, Spain, which is the reference Hospital) in the period 
January, 2001-December, 2005.
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Body measurements (weight and height) were taken during physical exam in 
underwear and barefoot. We used an Año-Sayol scale (reading interval 0 to 120 kg 
and a precision of 100 g) for the measurement of weight and a Holtain wall sta-
diometer (reading interval 60 to 210 cm, precision 0.1 cm) for the measurement 
of height.
We collected a sample of 217 births of babies who met the criteria of VLBW, 47 
of whom were excluded due to different reasons: perinatal mortality in 20 (9.2%), 
the finding of severe malformations or chromosomopathies in 6 (2.8%), severe neu-
rosensory disability and motor sequelae in 5 (2.3%), ethnic origin in 8 (3.7%) and 
other reasons (geographical distance to hospital and difficulties for transportation, 
absence of continuity in the evaluations of the pediatric health screening, etc.) in 8 
cases (3.7%).
The children (VLBW) in this cohort were divided in two subgroups: newborn 
infants who were appropriate for gestational age (AGA subgroup) and newborn 
infants who were small for gestational age (SGA subgroup). The difference between 
both groups was that birth weight and/or length were higher or equal/lower than 
two standard deviations below the average of a reference population for gestational 
age and sex, respectively. We used the growth reference charts for newborns from 
the anthropometric growth patterns of preterm from Carrascosa et al. [28]. In addi-
tion, when birth weight was lower than 1.000 g they were defined as extremely low 
birth weight (ELBW). Another way to classify newborns was based on gestational 
age: extremely preterm (EPT) when gestational age was lower than 28 weeks, very 
preterm (VPT) when gestational age was between 28–32 weeks, and late preterm 
(LPT) when gestational age was between 32–37 weeks.
A control group was established by recruiting children from a different obser-
vational epidemiological study made of an infant population (healthy full-term 
infants, Caucasian and children from Caucasian parents); the periodic evaluations 
followed the same patterns as those for VLBW infants (482 boys and 448 girls) [29].
An adequate catch-up growth in height or weight was defined when height or 
weight in VLBW infants, respectively, surpassed the value of 2 standard deviations 
below the mean in the growth charts of the control group [2–4].
3. Statistical analysis
Results are presented in the successive tables as percentages (%) and means (M) 
with corresponding standard deviations (s.d.) and confidence intervals (95% CI). 
The statistical analysis (descriptive statistics, Student’s t-test, analysis of variance, 
Chi-square and multiple logistic regression analysis) was executed with the pro-
gram Statistical Packages for the Social Sciences version 20.0 (Chicago, IL, USA). The 
statistical significance was reached with a P-value of 0.05.
This study was submitted and subsequently approved by the Ethics Committee 
for Human Investigation of the Navarra Hospital Complex, Pamplona, Spain (in 
compliance with the ethical standards of the 1964 Declaration of Hensinki and later 
amendments). Parents and/or legal guardians were aware of the characteristics and 
requirements of the study and provided acceptance for the participation in all cases.
4. Results
The sample of VLBW infants who have been recruited for this study consists of 
170 children (82 boys and 88 girls). In the aggregate, 40.6% (n = 69) of the infants 
were included as small for gestational age (SGA subgroup) and the remaining 59.4% 
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Figure 2. 
Distribution of VLBW according to the type of pregnancy.
(n = 101) as appropriate for gestational age (AGA subgroup). In the SGA subgroup, 
59.4% (n = 41) of children had a history of weight and height alterations at birth, 
while specific alterations of height (23.2%, n = 16) or weight (17.4%, n = 12) were 
less frequent (Figure 1).
Multiple pregnancies amount to 42.4% (n = 72), being twin pregnancies pre-
dominant, (Figure 2).
On the basis of gestational age, they have been subdivided into extremely 
preterm (n = 32, 18.8%), very preterm (n = 72, 42.4%) and late preterm (n = 66, 
38.8%) (Figure 3). Thirty-seven (21.8%) infants were included as ELBW.
Table 1 exposes and compares the values of the anthropometric measurements 
at birth of VLBW infants in the AGA and SGA subgroups and classified by sex. We 
do not appreciate statistically significant differences in the mean weight and height 
values at birth between the two groups. The values of gestational age were signifi-
cantly higher in the SGA subgroup than in the AGA subgroup.
Table 2 displays and compares the mean values for height, weight and growth 
rate in VLBW infants and the control group from birth to 10 years of age. Figures 
for height and weight were significantly lower in VLBW than in the control group. 
In contrast, growth rate in the first two years of life in was significantly higher in 
VLBW infants than in the individuals of the control group.
Figure 1. 
Classification of VLBW according to weight and/or height at birth.
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Figure 4 shows the percentage of VLBW infants who reached normal height 
at the different stages that were evaluated in the study. At age 2, 4 and 10 years, 
49.4%, 78.9% and 87.1%of infants, respectively, had gained normal height. In this 
sense, 8.2% of VLBW infants presented with normal height between ages 4 and 
10 years.
The analysis reveals that 86% of VLBW infants that had gained normal weight 
after the first year of life reached normal height (P < 0.001) by age 2 years. 
Additionally, 98.6% of VLBW infants with normal weight at age 2 had reached 
normal height (P < 0.001) by age 4. In the same way, 97.2% of VLBW infants with 
normal weight at age 4 appear with normal values for height (P < 0.001) by age 
10, 99.2% of VLBW infants with normal weight at age 6 showed normal values 
for height by age 8 (P < 0.001), and finally, all VLBW infants that presented with 
normal weight at age 10 had also normal height at this age (P < 0.001).
Table 3 states the comparison of mean values for height, weight and growth rate 
between AGA y SGA subgroups from birth to 10 years of age. The AGA subgroup 
features significantly higher values for height with respect to SGA subgroup at age 
1, 2, 3, 4 and 6, as well as higher values for weight at age 1, 2, 3 and 6. There were 
no statistically significant differences in growth rate between both groups in every 
stage evaluated.
Figure 5 shows the figures of the percentages of infants in the AGA and SGA 
subgroups that gained normal size at the different stages under assessment. There 
were no statistically significant differences between the groups, except at age 10: 
Figure 3. 












28.7 ± 1.9 33.3 ± 1.9 28.9 ± 2.1 32.6 ± 3.1
Weight (g) 1204.3 ± 222.8 1257.4 ± 179.9 1145.8 ± 229.7 1134.0 ± 256.5
Height (cm) 38.3 ± 3.1 39.0 ± 2.4 38.2 ± 2.6 37.4 ± 3.5
*Student’s t-test, p < 0.05 among AGA and SGA.
AGA: appropriate for gestational age. SGA: small weight for gestational age.
Table 1. 
Gestational age, weight and height data from VLBW infants at birth in both sexes (M ± SD).
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17% of children in the SGA subgroup (n = 12) and 10% of children in the AGA 
subgroup (n = 10) presented with low height values (P = 0.018).
Table 4 describes the mean values for height, weight and growth rate in ELBW 
(<1000 g) and VLBW (1001–1500 g) infants from birth to 10 years. Mean values 
for weight and height were significantly lower in ELBW than in VLBW in every age 
considered except for 10 years. There were no significant differences in growth rate 
between both groups in any period of age.
Figure 6 presents the percentages of VLBW (1000–1500 g; n = 133) and ELBW 
(<1000 g; n = 37) infants that reached normal height at the different ages under 
assessment. There were significant differences between groups at every age evalu-
ated. In this way, 7% of VLBW infants (n = 9) and 35% of ELBW infants (n = 13) 
showed short stature (P = 0.001) at age 10.
In the SGA subgroup, 7 out of the 12 children that presented with short stature 
at age 10 (7 of whom were ELBW) had reached normal values in height by age 14 (6 
of them had taken treatment with recombinant human growth hormone [rhGH]); 
the remaining 5 (3 of whom were ELBW) maintained short stature (3 of them 
had treatment with rhGH). Treatment with rhGH was started between ages 6.5 
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VLBW: very low birth weight.
Table 2. 
Changes in the values of height, weight and growth rate of VLBW and control group (M ± SD).
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Figure 4. 
Percentages of adequate catch-up growth in height in VLBW infants.
Height (cm)

















































































































AGA: appropriate for gestational age. SGA: small weight for gestational age.
Table 3. 
Changes in the values of height, weight and growth rate of VLBW (AGA and SGA subgroups. (M ± SD).
Current Topics in Caesarean Section
8
Figure 5. 
Percentages of adequate catch-up growth in height in AGA and SGA groups (chi-square).
Height (cm)

















































































































ELBW: extremely low birth weight. VLBW: very low birth weight.
Table 4. 
Changes in the values of height, weight and growth rate of VLBW (1000–1500 g) and ELBW (< 1000 g). 
(M ± SD).
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and 8.3 years. In the AGA subgroup, 2 of the 10 children that presented with short 
stature at age 10 (7 of whom were ELBW) had reached a normal height at 14 years 
(1 of them had received rhGH therapy at age 8.9 years) and 8 (6 of them ELBW) 
kept in short stature (1 of them started rhGH therapy at age 7.8 years, and 7 of them 
were not entitled to receive treatment due to normal responses in growth hormone 
stimulation tests).
Table 5 displays the results of the multiple logistic regression analysis conducted 
to study the association of neonatal clinical history with inappropriate catch-up 
growth in height at ages 2, 4, and 10. The analysis shows that the conditions of ELBW, 
SGA for height and preterm birth before 28 weeks of gestation were associated with 
inadequate catch-up growth in height at 2, 4, and 10 years. On the other side, SGA for 
Figure 6. 
Percentages of adequate catch-up growth in height in ELBW and VLBW infants (chi-square).
Items Inadequate catch-up growth in height
At 2 years
OR (95% CI) P-value
At 4 years
OR (95% CI) P-value
At 10 years
























































VLBW: very low birth weight. ELBW: extremely low birth weight. AGA: appropriate for gestational age. SGA: small 
weight for gestational age. LPT: late preterm. VPT: very preterm. EPT: extremely preterm.
Table 5. 
Logistic regression analysis of factors associated with inadequate catch-up growth.
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both weight and height was associated with inadequate catch-up growth only at age 
10, whereas preterm birth between 28 to 32 weeks of gestation was associated with 
inadequate catch-up growth only at ages 2 and 4. Additionally, multiple birth was not 
associated with inadequate catch-up growth at ages 2, 4 or 10 years.
5. Discussion
The terms “intrauterine growth restriction” (IUGR) and “small for gestational 
age” (SGA) newborn are not strictly equivalent concepts [30], since they are related 
to different chronological stages (fetal growth and anthropometric measurements 
at birth, respectively). Nevertheless, they refer to failure to reach the genetic growth 
potencial during the prenatal period as an adaptive response to an adverse uterine 
environment. In any way, both terms are used indistinctly in daily clinical practice 
in order to cluster those newborns whose weight and/or height at birth are equal to/
below 2 standard deviations under the average of a reference population on the basis 
of gestational age and sex. In this case, the majority of children included in the so-
called SGA group presented with a combined alteration in weight and height, whilst 
the proportion of children with exclusive weight or height disorder was slightly lower.
This definition requires a precise diagnosis of gestational age and the reg-
istration of anthropometric measurements after birth, whose values should be 
contrasted with reference standards for gestational age and sex. The choice of 
reference patterns is a determining factor in the assessment of newborn growth 
[31]. In fact, the variability of the anthropometric variables in relation to racial, 
genetic, social, environmental and maternal lifestyle factors make it advisable to 
use local or national growth reference charts. The charts from Lubchenco et al. [32], 
which were published in the 60s, have been widely used and are characterized by a 
contrasted clinical utility. At present, the most qualified local (Spanish) reference 
charts, which have been used in the present study, are the newborn (26–42 weeks of 
gestational age) weight and height charts from the anthropometric growth patterns 
of preterm from Carrascosa et al. [28].
Fetal development and intrauterine growth are complex processes in which 
continuous and harmonious cellular proliferation and differentiation take place. 
Multiple factors (maternal, fetal, placental and environmental) have been men-
tioned to have a negative impact on the fetus and set off a series of functional 
and structural adaptive changes that conclude in fetal growth restriction (in the 
so-called “thrifty phenotype hypothesis”). They are linked to different changes 
in hormone sensitivity and/or secretion that entails an increased risk of devel-
oping metabolic and/or endocrine disorders in adult life [33, 34]. In any way, 
most term newborns with previous intrauterine growth restriction manifest a 
compensatory growth (catch-up growth) after birth, mainly in the first year of 
life, that enables approximately 90% of the individuals to surpass the threshold 
of 2 SDs under the average in the reference population, or, in other words, to 
get normal height [2–4]. Even so, whenever this compensatory growth does not 
occur, a normal final height in adulthood is not likely to be reached. By knowing 
so, this event is considered one of the indications for rhGH therapy approved 
by the United States Food and Drug Administration (FDA), the European 
Medicines Agency (EMA) and the Growth Hormone Research Society, with 
the intention to boost the initial compensatory growth and/or to keep normal 
growth velocity [3, 35, 36].
The recent advances in obstetric and perinatal care have led to a considerable 
decrease in VLBW infants mortality; despite this, and owing to the potential 
sensorineural morbidity in this children, these patients are usually enlisted in 
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follow-up programmes whose goal is the early detection of neurodevelopmental 
problems [1, 37]. The improvement of these programmes has eased the standard-
ization of dietary and nutritional advices, and enabled growth monitoring in the 
first years of life. It also facilitates the analysis, as we performed in this study, of 
the evolution of anthropometric variables in VLBW infants [38].
The results obtained in this study confirm that, on one side, the VLBW new-
borns undergo a postnatal compensatory growth that is maximum during the first 
year of life, as it occurs in term newborns that are SGA. As a matter of fact, growth 
velocity during the first 12 months of life in VLBW was considerably higher than 
in the control group; this explains, to a great extent, the noticeably proportion 
of individuals in this group that reach normal height by age 2 years [39]. On the 
other side, this study remarks that VLBW infants have a lower rate and/or delay in 
the catch-up growth in height when comparing to that observed in full-term SGA 
infants [4, 16–18, 24, 25]. In point of fact, 50.6%, 21.1% and 12.9% of individuals, 
maintained short stature at age 2, 4 and 10, respectively; in other words, these 
individuals reached normal height in a similar percentage than that for full-term 
SGA infants at age 2. Additionally, barely 8.2% of children reached normal height 
between ages 4 to 10. Despite current data are inconsistent, these results are some-
how congruent with those exposed by the different authors that previously noticed 
that catch-up in VLBW infants could be delayed [12, 15, 40–44]. Nevertheless, none 
of the authors cited has screened the influence of catch-up growth in weight, which 
is concurrent with the catch-up in height and, in accordance to the data collected, 
plays a decisive role [24, 25]. In effect, a great majority of individuals who present 
with normal height at age 2, 4 and 10 have gained an adequate catch-up growth in 
weight in the previous evaluations. For this reason, these individuals should follow a 
strict nutritional control in order to raise an issue on the prescription of nutritional 
supplements with the challenge to get weight recovery as fast as possible [26, 45–47].
The findings of our study have direct implications on clinical practice. First of 
all, the assessment and comparison of the patterns of catch-up height gain in AGA 
and SGA groups present only small variances in the age range under consideration, 
except at age 10. At age 10, only 1 out of the 10 children did not register normal 
height in the AGA group, whilst approximately 1 in 5 children in the SGA subgroup 
still had short stature. In other words, the lower rate of catch-up growth in VLBW 
infants is slightly further reduced or delayed in SGA infants. On the other hand, it is 
important to emphasize that 1 in 3 children get normal height in both the AGA and 
the SGA groups between ages 2 and 4 years. This fact suggests that the implementa-
tion of the recommendation of the EMA and the Growth Hormone Research Society 
to postpone the beginning of rhGH therapy until the age of 4 years would be more 
applicable than implementing the recommendation of the FDA, which recommends 
the beginning of treatment at age 2 years.
The analysis of catch-up growth in ELBW infants merits particular attention. 
First, we detected that the majority of children that had not attained normal height 
by age 10 years in both the AGA and the SGA subgroups were infants born with 
ELBW. Second, there was a noticeable amount of children in the AGA subgroup that 
were not considered for hormone therapy when the response to growth hormone 
stimulation test was normal, in accordance with the current recommendations 
of the FDA, the EMA and the Growth Hormone Research Society. This fact fully 
explains the reason why children in the AGA subgroup with short stature at age 
10 years (the majority of them were VLBW) remained in the same situation at age 
14 and, presumably, in adulthood. Since current guidelines do not give consid-
eration to the option of beginning growth hormone therapy in AGA infants with 
normal GH secretion, we should reckon if these criteria should be revised in the 
case of children born with VLBW and, especially, those with ELBW.
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The multiple logistic regression analysis corroborated that ELBW and EPT 
infants were at higher risk of inadequate catch-up in height at 2, 4, and 10 years 
of age; additionally, they have an increased risk of short stature in adulthood. 
These results sustain the hypothesis of a potential benefit from GH treatment, 
independently of the adequacy of their birth weight and/or length for gestational 
age [18, 48–50].
In conclusion, the growth pattern of children born preterm has particular 
features. Approximately 85% and 53% of VLBW and ELBW infants, respectively, 
will attain normal height by 4 years of age. In contrast, those individuals with short 
stature at age 4 years are not likely to attain normal height in childhood. Catch-up in 
weight appears to be a decisive factor for catch-up in height, and, on this basis, we 
recommend a rigorous nutritional follow-up in these individuals. If these measures 
do not help improve catch-up in height, they may be eligible for the establishment 
of rhGH therapy.
© 2021 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
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by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
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